Zymergen INC.

Biofacturing company

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $80K in lobbying spend across 3 quarterly filings, Zymergen INC is an active lobbying client. Their lobbying covers 3 issue areas.

$80K
Total Spend
1
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2021$80K

Issues Lobbied

ManufacturingMEDScience/Technology

Lobbying Firms

Tiber Creek Group

Lobbyists

Jeffrey ShapiroJennifer OlsonAlix BurnsCorey MalmgrenJohn Twomey

Government Agencies Targeted

These are the government entities that Zymergen INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESOffice of Science & Technology Policy (OSTP)SENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Manufacturing, MED, Science/Technology

Enhanced investment in biomanufacturing; Supply chain resilience.

Issues related to global supply chains.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Tech Lobbying
Industry overview and top spenders

Related Investigations

Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Intuitive Surgical, INC.
$3.2M total spend
Helix, INC.
$1.8M total spend
Trimble INC.
$1.4M total spend
Cedars-sinai Medical Center
$1.2M total spend
Mediatek USA INC.
$1.1M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.